India's Ranbaxy Sees Generic Deal For Nexium Kicking Off This Year
This article was originally published in PharmAsia News
A deal between Ranbaxy Laboratories and AstraZeneca for a generic version of the U.K.-based firm's proton pump inhibitor Nexium (esomeprazole) is set to take place by the end of this year, ending a delay of more than a year
You may also be interested in...
The UK's Advertising Standards Authority will closely monitor the marketing communications of dietary supplements e-tailer Health Solutions after it failed to provide a substantive response to health claims regulation breaches.
Consensus report CR511 from the Association for the Advancement of Medical Instrumentation highlights common system elements for engineers, and outlines safety and risk-control measures that manufacturers and caregivers should consider.
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.